Authors: Marconi, P Tamura, M Moriuchi, S Krisky, DM Niranjan, A Goins, WF Cohen, JB Glorioso, JC

Citation: P. Marconi et al., Connexin 43-enhanced suicide gene therapy using herpesviral vectors, MOL THER, 1(1), 2000, pp. 71-81

Authors: Moriuchi, S Krisky, DM Marconi, PC Tamura, M Shimizu, K Yoshimine, T Cohen, JB Glorioso, JC

Citation: S. Moriuchi et al., HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma, GENE THER, 7(17), 2000, pp. 1483-1490

Authors: Wolfe, D Goins, WF Yamada, M Moriuchi, S Krisky, DM Oligino, TJ Marconi, PC Fink, DJ Glorioso, JC

Citation: D. Wolfe et al., Engineering herpes simplex virus vectors for CNS applications, EXP NEUROL, 159(1), 1999, pp. 34-46

Authors: Krisky, DM Wolfe, D Goins, WF Marconi, PC Ramakrishnan, R Mata, M Rouse, RJD Fink, DJ Glorioso, JC

Citation: Dm. Krisky et al., Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons, GENE THER, 5(12), 1998, pp. 1593-1603

Authors: Suzuki, T Piche, A Kasono, K Xiang, JL Gomez-Navarro, J Moriuchi, S Krisky, DM Oligino, T Glorioso, JC Curiel, TJ Curiel, DT

Citation: T. Suzuki et al., Efficient gene delivery into Epstein-Barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy, BIOC BIOP R, 252(3), 1998, pp. 686-690